Dishman Pharmaceuticals and Chemicals Ltd. is a leading global player in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Fine Chemicals. The company has a rich history of over 60 years in the industry and has been at the forefront of innovation and technology.
Dishman has a strong focus on quality and compliance, and has been awarded the ISO 9001:2008 certification. The company has a state-of-the-art manufacturing facility in India that is compliant with cGMP standards.
Dishman’s product portfolio includes a wide range of APIs and Fine Chemicals for the pharmaceutical, biotechnology, and nutraceutical industries. The company has a strong R&D focus and has a dedicated team of scientists working on the development of new products and processes.
Dishman has a workforce of over 1500 employees, and its products are sold in over 60 countries around the world. The company has a strong growth strategy and is looking to expand its operations in the coming years.
Dishman Pharmaceuticals and Chemicals Ltd. is listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
Website: www.dishman.com